microbiome therapy

LYON, France, June 26, 2026 MaaT Pharma announced plans to request a re-examination of the European Medicines Agency (EMA)...

Lyon, France, May 20, 2026 MaaT Pharma announced that the Committee for Medicinal Products for Human Use (CHMP) of...

MOUNTAIN VIEW, Calif., ARLINGTON, Va., and LONDON, England, May 13, 2026 Osel Inc., in partnership with March of Dimes...

GHENT, Belgium, May 2, 2026 MRM Health announced the initiation of its Phase 2b STARFISH-UC clinical trial (NCT07296315) evaluating...

GLASGOW, Scotland, April 29, 2026 EnteroBiotix Limited has announced the successful completion of a £19 million ($25 million) financing...

CAMBRIDGE, Mass., April 2, 2026 Vedanta Biosciences announced that its pivotal Phase 3 RESTORATiVE303 clinical trial of VE303 will...

LYON, France, April 1, 2026 MaaT Pharma has announced the publication of CHRONOS study data in the peer-reviewed Bone...